Blood-induced interference of glucose sensor function in vitro: Implications for in vivo sensor function

Journal of Diabetes Science and Technology

Volumn 1, Issue 6, 2007, Pages 842-849

  Klueh, Ulrike ^a,b   Liu, Zenghe ^c   Ouyang, Tianmei ^c   Cho, Brian ^c   Feldman, Ben ^c   Henning, Timothy P ^c   Kreutzer, Don ^a,b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c ABBOTT LABORATORIES   (United States)

Author keywords

Blood; Blood clots; Diabetes; Implantable glucose sensor; Red blood cells; Sensor function in vitro; Tissue hemorrhages

Indexed keywords

EID: 84887251507     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680700100607     Document Type: Article

References (18)

1. Buhling KJ, Kurzidim B, Wolf C, Wohlfarth K, Mahmoudi M, Wascher C, Siebert G, Dudenhausen JW. Introductory experience with the continuous glucose monitoring system (CGMS; Medtronic Minimed) in detecting hyperglycemia by comparing the self-monitoring of blood glucose (SMBG) in non-pregnant women and in pregnant women with impaired glucose tolerance and gestational diabetes. Exp Clin Endocrinol Diabetes. 2004;112(10):556-60.
2. Djakoure-Platonoff C, Radermercker R, Reach G, Slama G, Selam JI. Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions. Diabetes Metab. 2003;29(2 Pt 1):159-62.
3. Feldman B, Brazg R, Schwartz S, Weinstein R. A continuous glucose sensor based on wired enzyme technology-results from a 3-day trial in patients with type 1 diabetes. Diabetes Technol Ther. 2003;5(5):769-79.
4. Kapitza C, Lodwig V, Obermaier K, Wientjes KJ, Hoogenberg K, Jungheim K, Heinemann L. Continuous glucose monitoring: reliable measurements for up to 4 days with the SCGM1 system. Diabetes Technol Ther. 2003;5(4):609-14.
5. Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, Di Mario U, Annuzzi G, Genovese S, Riccardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care. 2002;25(2):347-52.
6. Tansey MJ, Beck RW, Buckingham BA, Mauras N, Fiallo-Scharer R, Xing D, Killman C, Tamborlane WV, Ruedy KJ. Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. Diabetes Technol Ther. 2005;7(1):109-14.
7. Gifford R, Kehoe JJ, Barnes SL, Kornilayev BA, Alterman MA, Wilson GS. Protein interactions with subcutaneously implanted biosensors. Biomaterials. 2006;27(12):2587-98.
8. Gerritsen M, Jansen JA, Kros A, Vriezema DM, Sommerdijk NA, Nolte RJ, Lutterman JA, Van Hovell SW, Van der Gaag A. Influence of inflammatory cells and serum on the performance of implantable glucose sensors. J Biomed Mater Res. 2001;54(1):69-75.
9. Qi J, Kreutzer DL. Fibrin activation of vascular endothelial cells. Induction of IL-8 expression. J Immunol. 1995;155(2):867-76.
10. Friedl KE. Analysis: overcoming the "valley of death": mouse models to accelerate translational research. Diabetes Technol Ther. 2006;8(3):413-4.
11. Klueh U, Liu Z, Cho B, Ouyang T, Feldman B, Henning TP, Kaur M, Kreutzer D. Continuous glucose monitoring in normal mice and mice with prediabetes and diabetes. Diabetes Technol Ther. 2006;8(3):402-12.
12. Rebrin K, Fischer U, Hahn von Dorsche H, von Woetke T, Abel P, Brunstein E. Subcutaneous glucose monitoring by means of electrochemical sensors: fiction or reality? J Biomed Eng. 1992;14(1):33-40.
13. Klueh U, Kaur M, Montrose DC, Kreutzer DL. Inflammation and glucose sensors: use of dexamethasone to extend glucose sensor function and life span in vivo. J Diabetes Sci Technol. 2007;1(4):496-504.
14. Javid PJ, Halwick DR, Betit P, Thompson JE, Long K, Zhang Y, Jaksic T, Agus MS. The first use of live continuous glucose monitoring in patients on extracorporeal life support. Diabetes Technol Ther. 2005;7(3):431-9.
15. Lutgers HL, Hullegie LM, Hoogenberg K, Sluiter WJ, Dullaart RP, Wientjes KJ, Schoonen AJ. Microdialysis measurement of glucose in subcutaneous adipose tissue up to three weeks in type 1 diabetic patients. Neth J Med. 2000;57(1):7-12.
16. Klueh U, Dorsky DI, Kreutzer DL. Enhancement of implantable glucose sensor function in vivo using gene transfer-induced neovascularization. Biomaterials. 2005;26(10):1155-63.
17. Klueh U, Kreutzer DL. Murine model of implantable glucose sensors: a novel model for glucose sensor development. Diabetes Technol Ther. 2005;7(5):727-37.
18. Kvist PH, Jensen HE. Recent advances in continuous glucose monitoring: biocompatibility of glucose sensors for implantation in subcutis. J Diabetes Sci Technol. 2007;1(5):746-52.